Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Equity Ratio: 2019-2024

Historic Equity Ratio for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to 0.32.

  • Eton Pharmaceuticals' Equity Ratio fell 50.37% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year decrease of 50.37%. This contributed to the annual value of 0.32 for FY2024, which is 34.19% down from last year.
  • According to the latest figures from FY2024, Eton Pharmaceuticals' Equity Ratio is 0.32, which was down 34.19% from 0.49 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Equity Ratio registered a high of 0.64 during FY2021, and its lowest value of 0.32 during FY2024.
  • Moreover, its 3-year median value for Equity Ratio was 0.49 (2023), whereas its average is 0.44.
  • In the last 5 years, Eton Pharmaceuticals' Equity Ratio rose by 7.86% in 2021 and then slumped by 34.19% in 2024.
  • Over the past 5 years, Eton Pharmaceuticals' Equity Ratio (Yearly) stood at 0.60 in 2020, then climbed by 7.86% to 0.64 in 2021, then declined by 18.60% to 0.52 in 2022, then dropped by 6.67% to 0.49 in 2023, then tumbled by 34.19% to 0.32 in 2024.